mdlinx mdlinx
Latest (92) Full Text Articles (1945) Focus on Neurologic Infections Article Summary

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
The Lancet Infectious Diseases,  Clinical Article

Cornely OA et al. – Fidaxomicin could be an alternative treatment for infection with C difficile, with similar efficacy and safety to vancomycin.

Methods
  • In this multicentre, double-blind, randomised, non-inferiority trial, the authors enrolled patients from 45 sites in Europe and 41 sites in the USA and Canada between April 19, 2007, and Dec 11, 2009.
  • Eligible patients were aged 16 years or older with acute, toxin-positive C difficile infection.
  • Patients were randomly allocated (1:1) to receive oral fidaxomicin (200 mg every 12 h) or oral vancomycin (125 mg every 6 h) for 10 days.
  • The primary endpoint was clinical cure, defined as resolution of diarrhoea and no further need for treatment.
  • An interactive voice-response system and computer-generated randomisation schedule gave a randomisation number and medication kit number for each patient.
  • Participants and investigators were masked to treatment allocation.
  • Non-inferiority was prespecified with a margin of 10%.
  • Modified intention-to-treat and per-protocol populations were analysed.

Results
  • Of 535 patients enrolled, 270 were assigned fidaxomicin and 265 vancomycin.
  • After 26 patients were excluded, 509 were included in the modified intention-to-treat (mITT) population.
  • 198 (91•7%) of 216 patients in the per-protocol population given fidaxomicin achieved clinical cure, compared with 213 (90•6%) of 235 given vancomycin, meeting the criterion for non-inferiority (one-sided 97.5% CI -4.3%).
  • Non-inferiority was also shown for clinical cure in the mITT population, with 221 (87.7%) of 252 patients given fidaxomicin and 223 (86.8%) of 257 given vancomycin cured (one-sided 97.5% CI -4.9%).
  • nalyses of the primary endpoint in the mITT population, outcomes in the two treatment groups did not differ significantly; although patients receiving concomitant antibiotics for other infections had a higher cure rate with fidaxomicin (46 [90.2%] of 51) than with vancomycin (33 [73.3%] of 45; p=0.031).
  • Occurrence of treatment-emergent adverse events did not differ between groups. 20 (7.6%) of 264 patients given at least one dose of fidaxomicin and 17 (6.5%) of 260 given vancomycin died.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Infectious Disease

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Infectious Disease Articles

Last month's top read Top Articles of 2013

1 Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children Clinical Infectious Diseases, March 17, 2014    Clinical Article

2 A comparison of intense pulsed light and laser treatment of telangiectases in patients with systemic sclerosis: A within-subject randomized trial Rheumatology, March 17, 2014    Clinical Article

3 Treatment of bacterial vaginosis: what we have and what we miss Expert Opinion on Pharmacotherapy, March 17, 2014    Review Article

4 Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy Journal of Clinical Virology, March 17, 2014    Clinical Article

5 High-risk oral HPV viral load in the U.S. population, NHANES 2009-2010 The Journal of Infectious Diseases, March 17, 2014    Clinical Article

6 Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761) Antiviral Therapy , March 17, 2014    Clinical Article

7 CD4+ T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: A prospective cohort analysis Antiviral Therapy , March 17, 2014    Clinical Article

8 Sexual risk trajectories among MSM in the United States: Implications for pre-exposure prophylaxis delivery Journal of Acquired Immune Deficiency Syndromes, March 17, 2014    Clinical Article

9 Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis Clinical Infectious Diseases, March 24, 2014    Clinical Article

10 Combination antiretroviral treatment for women previously treated only in pregnancy: Week 24 results of AIDS clinical trials group protocol A5227 Journal of Acquired Immune Deficiency Syndromes, March 17, 2014    Clinical Article

11 Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients Clinical Nutrition, March 13, 2014    Clinical Article

12 Does HIV infection promote early kidney injury in women? Antiviral Therapy , March 17, 2014    Clinical Article

13 Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry European Journal of Nuclear Medicine & Molecular Imaging, March 17, 2014    Review Article

14 HIV viremia and incidence of non-hodgkin lymphoma in patients successfully treated with antiretroviral therapy Clinical Infectious Diseases, March 14, 2014    Clinical Article

15 Safety analysis of Ziagen(abacavir sulfate) in postmarketing surveillance in Japan Pharmacoepidemiology and Drug Safety, March 17, 2014    Clinical Article

16 Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery Clinical Infectious Diseases, February 27, 2014    Clinical Article

17 Severe cutaneous adverse reactions related to systemic antibiotics Clinical Infectious Diseases, March 17, 2014    Clinical Article

18 Long-term changes in carotid intima-media thickness among HIV-infected children and young adults Antiviral Therapy , March 17, 2014    Clinical Article

19 Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons The Journal of Infectious Diseases, March 26, 2014    Clinical Article

20 Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009 Clinical Infectious Diseases, March 17, 2014    Clinical Article

Indexed Journals in Infectious Disease: Journal of Infection, AIDS, American Journal of Infection Controlmore

Other Topics in Infectious Disease

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close